280 related articles for article (PubMed ID: 32410046)
1. Follicular lymphoma transforming to DLBCL and reverting back to follicular lymphoma at relapse-a case report.
Suresh Babu MC; Thottian AGF; Lokanatha D; Jacob LA; Lokesh KN; Rudresha AH; Rajeev LK; Smitha S; Hassan SA; Ashok KP; Premalatha CS; Suma MN
J Egypt Natl Canc Inst; 2020 May; 32(1):22. PubMed ID: 32410046
[TBL] [Abstract][Full Text] [Related]
2. CD 30-positive transformed follicular lymphoma: two case reports and literature review.
Montes-Moreno S; Climent F; González de Villambrosía S; González Barca EM; Batlle A; Insunza A; Pané-Foix M; Colorado M; Martin-Sánchez G; Espiga CR; Conde E; Piris MA
Histopathology; 2015 Dec; 67(6):918-22. PubMed ID: 25953530
[TBL] [Abstract][Full Text] [Related]
3. Standard R-CHOP therapy in follicular lymphoma and diffuse large B-cell lymphoma.
Tomita N; Takasaki H; Fujisawa S; Miyashita K; Ogusa E; Kishimoto K; Matsuura S; Sakai R; Koharazawa H; Yamamoto W; Fujimaki K; Fujita H; Ishii Y; Taguchi J; Kuwabara H; Motomura S; Ishigatsubo Y
J Clin Exp Hematop; 2013; 53(2):121-5. PubMed ID: 23995108
[TBL] [Abstract][Full Text] [Related]
4. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Bischin AM; Dorer R; Aboulafia DM
Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
[TBL] [Abstract][Full Text] [Related]
5. A Case of Transformation of Primary Cutaneous Follicle Center Lymphoma to Diffuse Large B-Cell Lymphoma Involving the Parotid Gland and Cervical Lymph Nodes.
King ML; Vengaloor Thomas T; Albert AA; Joseph S; Ramachandran Nair L; Lam JT; Woods WC; Nittala M; Vijayakumar S
Am J Case Rep; 2019 Aug; 20():1273-1278. PubMed ID: 31462626
[TBL] [Abstract][Full Text] [Related]
6. Long-term clinical course of immunotactoid glomerulopathy complicated with diffuse large B-cell lymphoma.
Takahashi H; Sano T; Kawamura S; Sano K; Miyasaka R; Yamazaki T; Sakakibara M; Abe T; Hashimoto K; Nagaoka M; Kamata M; Naito S; Aoyama T; Moriya R; Takeuchi Y
CEN Case Rep; 2022 May; 11(2):184-190. PubMed ID: 34569002
[TBL] [Abstract][Full Text] [Related]
7. CD5-positive follicular lymphoma: a case report and literature review.
Sekiguchi Y; Imai H; Wakabayashi M; Sawada T; Ichikawa K; Komatsu N; Noguchi M
Intern Med; 2011; 50(8):899-904. PubMed ID: 21498939
[TBL] [Abstract][Full Text] [Related]
8. Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphoma.
Dakhil S; Hermann R; Schreeder MT; Gregory SA; Monte M; Windsor KS; Hurst D; Chai A; Brewster M; Richards P
Leuk Lymphoma; 2014 Oct; 55(10):2335-40. PubMed ID: 24471908
[TBL] [Abstract][Full Text] [Related]
9. Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma: systematic review and economic evaluation.
Knight C; Hind D; Brewer N; Abbott V
Health Technol Assess; 2004 Sep; 8(37):iii, ix-xi, 1-82. PubMed ID: 15361313
[TBL] [Abstract][Full Text] [Related]
10. Orbital MALT Lymphoma after Autologous Stem Cell Transplantation for Follicular Lymphoma as Relapse of Diffuse Large B-Cell Lymphoma.
Matsuo T; Tanaka T; Fujii N
J Clin Exp Hematop; 2017; 56(3):170-175. PubMed ID: 28331132
[TBL] [Abstract][Full Text] [Related]
11. Composite T lymphoblastic leukemia/lymphoma and diffuse large B-cell lymphoma: case report.
Niino D; Ohsaki K; Arakawa F; Watanabe J; Kimura Y; Kiyasu J; Takeuchi M; Miyoshi H; Yoshida M; Sugita Y; Ohshima K; Okamura T
Pathol Int; 2011 Jun; 61(6):363-8. PubMed ID: 21615612
[TBL] [Abstract][Full Text] [Related]
12. [Occurrence of follicular small cleaved cell lymphoma following chemotherapy for diffuse large cell lymphoma].
Saito S; Hayashi K; Ohnoshi T; Kawashima K; Matsutomo S; Tagawa S; Yoshino T; Nishiuchi R; Kimura I
Rinsho Ketsueki; 1994 Jul; 35(7):676-81. PubMed ID: 8065020
[TBL] [Abstract][Full Text] [Related]
13. [Primary malignant lymphoma arising from the nipple and areolar area of the breast].
Nakane T; Yamane T; Shibata H; Aoyama Y; Hasegawa T; Sakamoto C; Nakamae H; Terada Y; Ohta K; Hino M
Rinsho Ketsueki; 2003 Nov; 44(11):1107-9. PubMed ID: 14689876
[TBL] [Abstract][Full Text] [Related]
14. Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma.
Magnano L; Balagué O; Dlouhy I; Rovira J; Karube K; Pinyol M; Rivas-Delgado A; Costa D; Martínez-Trillos A; González-Farre B; Martínez-Pozo A; Giné E; Colomer D; Delgado J; Villamor N; Campo E; López-Guillermo A
Ann Oncol; 2017 Nov; 28(11):2799-2805. PubMed ID: 29045517
[TBL] [Abstract][Full Text] [Related]
15. Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial.
Watanabe T; Tobinai K; Wakabayashi M; Morishima Y; Kobayashi H; Kinoshita T; Suzuki T; Yamaguchi M; Ando K; Ogura M; Taniwaki M; Uike N; Yoshino T; Nawano S; Terauchi T; Hotta T; Nagai H; Tsukasaki K;
Lancet Haematol; 2018 Nov; 5(11):e520-e531. PubMed ID: 30389034
[TBL] [Abstract][Full Text] [Related]
16. A unique composite follicular lymphoma and mantle cell lymphoma with a mixed cell pattern and aggressive course.
Liu Y; Li P; Guo Y; Fan L; Wang L; Zhu J; Huang G; Yan Q; Wang Z
Am J Clin Pathol; 2014 May; 141(5):737-41. PubMed ID: 24713749
[TBL] [Abstract][Full Text] [Related]
17. Value of surveillance computed tomography in the follow-up of diffuse large B-cell and follicular lymphomas.
Lin TL; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Tang TC; Chang H; Hung YS; Lu SC
Ann Hematol; 2012 Nov; 91(11):1741-5. PubMed ID: 22729139
[TBL] [Abstract][Full Text] [Related]
18. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
[TBL] [Abstract][Full Text] [Related]
19. Low grade follicular lymphoma with high proliferation index; diagnostic and management issues.
Das S; Basu D; Dubashi B; Jain A
Indian J Pathol Microbiol; 2012; 55(4):516-8. PubMed ID: 23455792
[TBL] [Abstract][Full Text] [Related]
20. A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival.
Hans CP; Weisenburger DD; Vose JM; Hock LM; Lynch JC; Aoun P; Greiner TC; Chan WC; Bociek RG; Bierman PJ; Armitage JO
Blood; 2003 Mar; 101(6):2363-7. PubMed ID: 12424193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
